Studies of the activation of factor VII bound to tissue factor

Blood

Volumn 87, Issue 9, 1996, Pages 3738-3748

  Rao, L Vijaya Mohan ^a   Williams, Todd ^b   Rapaport, Samuel I ^b  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING; HEMOSTASIS; HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION;

EID: 0029917898     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.9.3738.bloodjournal8793738     Document Type: Article

References (26)

1. Rao LVM, Rapaport SI, Bajaj SP: Activation of human factor VII in the initiation of tissue factor-dependent coagulation. Blood 68:685, 1986
2. Rao LVM, Rapaport SI: Activation of factor VII bound to tissue factor: A key early step in the tissue factor pathway of blood coagulation. Proc Natl Acad Sci USA 85:6687, 1988
3. Nemerson Y, Repke D: Tissue factor accelerates the activation of coagulation factor VII: The role of a bifunctional coagulation cofactor. Thromb Res 40:351, 1985
4. Rapaport SI, Rao LVM: Initiation and regulation of tissue factor dependent blood coagulation. Arterioscler Thromb 12:1111, 1992
5. Nakagaki T, Foster DC, Berkner KL, Kisiel W: Initiation of the extrinsic pathway of blood coagulation: Evidence for the tissue factor dependent autoactivation of human coagulation factor VII. Biochem 30:10819, 1991
6. Yamamoto M, Nakagaki T, Kisiel W: Tissue factor dependent autoactivation of human blood coagulation factor VII. J Biol Chem 267:19089, 1992
7. Neuenschwander PF, Morrissey JH: Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. Analysis of a mutant with a selective deficiency in activity. J Biol Chem 267:14477, 1992
8. Neuenschwander PF, Fiore MM, Morrissey JH: Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. J Biol Chem 268:21489, 1993
9. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC: Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 81:734, 1993
10. Rao LVM: Characterization of anti-tissue factor antibody and its use in immunoaffinity purification of human tissue factor. Thromb Res 51:373, 1988
11. Mimms LT, Zampighi G, Nozaki Y, Tanford C, Reynolds JA: Phospholipid vesicle formation and transmembrane protein incorporation using octylglucoside. Biochem 20.833, 1981
12. Broze GJ Jr, Leykam JE, Schwartz BD, Miletich JP: Purification of human brain tissue factor. J Biol Chem 260:10917, 1985
13. Bach R, Gentry R, Nemerson Y: Factor VII binding to tissue factor in reconstituted phospholipid vesicles: Induction of cooperativity by phosphatidylserine. Biochem 25:4007, 1986
14. Hamamoto T, Yamamoto M, Nordfang O, Petersen JGL, Foster DC, Kisiel W: Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces. J Biol Chem 268:8704, 1993
15. Bajaj SP, Rapaport SI, Prodanos C: A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep Biochem 11:397, 1981
16. Rao LVM, Robinson T, Hoang AD: Factor VIIa/tissue factor-catalyzed activation of factors DC and X on a cell surface and in suspension: A kinetic study. Thromb Haemost 67:654, 1992
17. Usharani P, Warn-Cramer BJ, Kasper CK, Bajaj SP: Characterization of three abnormal factor DC variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia-B. J Clin Invest 75:76, 1985
18. Fleck RA, Rao LVM, Rapaport SI, Varki N: Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 59:421, 1990
19. Callander NS, Rao LVM, Nordfang O, Sandset PM, Wam-Cramer B, Rapaport SI: Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa. J Biol Chem 267:876, 1992
20. Le DT, Rapaport SI, Rao LVM: Relations between factor VIIa binding and expression of factor VIIa/tissue factor catalytic activity on cell surfaces. J Biol Chem 267:15447, 1992
21. +, phospholipids and tissue factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII. Biochem J 265:327, 1990
22. Fair DS, MacDonald MJ: Cooperative interaction between factor VII and cell surface-expressed tissue factor. J Biol Chem 262:11692, 1987
23. Sakai T, Lund-Hansen T, Paborsky L, Pedersen AH, Kisiel W: Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). J Biol Chem 264:9980, 1989
24. Le DT, Rapaport SI, Rao LVM: Studies of the mechanism for enhanced cell surface factor VIIa/tissue factor activation of factor X in fibroblast monolayers after their exposure to N-ethylmalemide. Thromb Haemost 72:848, 1994
25. Rao LVM, Nordfang O, Hoang AD, Pendurthi UR: Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/ factor Xa-induced inhibition of factor VIIa/tissue factor activity. Blood 85:121, 1995
26. Hedner U: Factor VIIa in the treatment of haemophilia. Blood Coag Fibrinol 1:307, 1990